European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading

European equities traded in the US as American depositary receipts rose late Thursday morning, gaining 0.35% to 1,403.4 on the S&P Europe Select ADR Index. From continental Europe, the gainers were le

MT NewswiresMay 9 23:03

European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Wednesday Trading

European equities traded in the US as American depositary receipts were trending modestly higher late Wednesday morning, rising 0.34% to 1,399.71 on the S&P Europe Select ADR Index. From continental E

MT NewswiresMay 8 23:26

It's Probably Less Likely That Adaptimmune Therapeutics Plc's (NASDAQ:ADAP) CEO Will See A Huge Pay Rise This Year

Key Insights Adaptimmune Therapeutics' Annual General Meeting to take place on 14th of May Total pay for CEO Ad Rawcliffe includes US$650.0k salary Total compensation is similar to the industry av

Simply Wall StMay 8 18:48

Bank Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher Tuesday

Bank stocks helped European equities traded in the US as American depositary receipts higher late Tuesday morning, rising 0.77% to 1,396.19 on the S&P Europe Select ADR Index. From continental Europe,

MT NewswiresMay 7 23:07

European Equities Traded in the US as American Depositary Receipts Rise Modestly Higher in Thursday Trading

European equities traded in the US as American depositary receipts were trending modestly higher Thursday morning, rising 0.25% to 1,364.91 on the S&P Europe Select ADR Index. From continental Europe,

MT NewswiresMay 2 23:29

Adaptimmune to Report Q1 2024 Financial and Business Updates on Wednesday, May 15, 2024

Philadelphia, Pennsylvania and Oxford, United Kindgom--(Newsfile Corp. - May 1, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company redefining the treatment of solid tumor cancers with cell

newsfileMay 2 00:00